ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+23.25%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(-16%)
Cap. Flow
-$45.8M
Cap. Flow
% of AUM
-31.54%
Top 10 Holdings %
Top 10 Hldgs %
61.26%
Holding
90
New
19
Increased
8
Reduced
10
Closed
22
Top Buys
| 1 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
$9.75M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
$6.47M |
| 3 |
Savara
SVRA
|
$6.27M |
| 4 |
Vera Therapeutics
VERA
|
$4.33M |
| 5 |
Insmed
INSM
|
$3.72M |
Top Sells
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
$16.3M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$11.5M |
| 3 |
Structure Therapeutics
GPCR
|
$7.82M |
| 4 |
Biohaven
BHVN
|
$7.46M |
| 5 |
ADMA Biologics
ADMA
|
$7.36M |
Sector Composition
| 1 | Healthcare | 90.31% |
| 2 | Communication Services | 0.31% |
| 3 | Consumer Staples | 0.05% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Xenon Pharmaceuticals
XENE
$2.98B
| $13.4M | 9.08% | 290,535 +62,535 | +27% | +$2.88M |
|
|
ALIM
2
DELISTED
Alimera Sciences, Inc.
ALIM
| $11.5M | 7.8% | 2,660,000 -274,108 | -9% | -$1.18M |
|
3
Axsome Therapeutics
AXSM
$6.05B
| $11M | 7.46% | 138,000 +46,000 | +50% | +$3.66M |
|
|
4
Alpha Architect 1-3 Month Box ETF
BOXX
$7.91B
| $9.75M | 6.62% | +92,700 | New | +$9.75M |
|
|
5
Vera Therapeutics
VERA
$1.38B
| $9.46M | 6.42% | 615,000 +281,319 | +84% | +$4.33M |
|
6
Xtant Medical Holdings
XTNT
$83.3M
| $9.07M | 6.16% | 8,027,593 -906,769 | -10% | -$1.02M |
|
|
7
Catalyst Pharmaceutical
CPRX
$2.52B
| $6.47M | 4.39% | +385,000 | New | +$6.47M |
|
|
8
Savara
SVRA
$567M
| $6.27M | 4.25% | +1,333,000 | New | +$6.27M |
|
9
Oric Pharmaceuticals
ORIC
$994M
| $6.22M | 4.22% | 676,000 +257,294 | +61% | +$2.37M |
|
10
Olema Pharmaceuticals
OLMA
$375M
| $5.8M | 3.94% | 413,607 +78,607 | +23% | +$1.1M |
|
11
Astria Therapeutics
ATXS
$349M
| $5.61M | 3.81% | 730,000 -617,088 | -46% | -$4.74M |
|
|
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.09M | 3.45% | 71,000 +43,000 | +154% | +$3.08M |
|
|
13
ADMA Biologics
ADMA
$4.12B
| $4.95M | 3.36% | 1,095,000 -1,628,011 | -60% | -$7.36M |
|
14
Soleno Therapeutics
SLNO
$3.6B
| $4.22M | 2.87% | 104,909 +57,828 | +123% | +$2.33M |
|
|
15
Insmed
INSM
$28.8B
| $3.72M | 2.52% | +120,000 | New | +$3.72M |
|
16
Immunovant
IMVT
$2.56B
| $3.37M | 2.29% | +80,000 | New | +$3.37M |
|
17
Ascendis Pharma
ASND
$11.8B
| $3.15M | 2.14% | +25,000 | New | +$3.15M |
|
|
CBAY
18
DELISTED
Cymabay Therapeutics
CBAY
| $2.62M | 1.78% | 111,000 -689,000 | -86% | -$16.3M |
|
19
Sagimet Biosciences
SGMT
$244M
| $2.53M | 1.72% | 483,181 | – | – |
|
20
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.31M | 1.57% | 65,000 -197,000 | -75% | -$7.01M |
|
|
MRNS
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.17M | 1.48% | 200,000 +74,967 | +60% | +$815K |
|
22
enVVeno Medical
NVNO
$15.4M
| $1.77M | 1.2% | +344,471 | New | +$1.77M |
|
23
Amylyx Pharmaceuticals
AMLX
$836M
| $1.76M | 1.19% | 119,526 -415,174 | -78% | -$6.11M |
|
24
Cytokinetics
CYTK
$4.23B
| $1.67M | 1.13% | +20,000 | New | +$1.67M |
|
|
ALPN
25
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.5M | 1.02% | +78,723 | New | +$1.5M |
|